The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia

Krysiak Robert; Gilowski Wojciech; Okopien Boguslaw

首页> 外文期刊>Cardiovascular therapeutics >The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia

【24h】

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia

机译：睾丸激素和非诺贝特（单独或组合使用）对迟发性性腺功能减退和致动脉粥样硬化血脂异常的男性心脏代谢危险因素的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Oral testosterone was found to reduce plasma levels of HDL cholesterol. No previous study has examined the effect of fibrates, known to increase HDL cholesterol, in patients with low testosterone levels requiring testosterone replacement.

机译：简介：口服睾丸激素可降低血浆HDL胆固醇水平。先前的研究未曾研究过贝特类药物（已知会增加HDL胆固醇）对睾丸激素水平低且需要更换睾丸激素的患者的影响。

著录项

来源
《Cardiovascular therapeutics》 |2015年第5期|共5页
作者
Krysiak Robert; Gilowski Wojciech; Okopien Boguslaw;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Androgens; Atherogenic dyslipidemia; Fibrates; Hypogonadism; Insulin resistance; Testosterone replacement;

机译：雄激素;动脉粥样硬化血脂异常;贝特类;性腺功能减退;胰岛素抵抗;睾丸激素替代;

相似文献

外文文献
中文文献
专利

1. The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia [J] . Krysiak Robert, Gilowski Wojciech, Okopien Boguslaw Cardiovascular therapeutics . 2015,第5期

机译：睾丸激素和非诺贝特（单独或组合使用）对迟发性性腺功能减退和致动脉粥样硬化血脂异常的男性心脏代谢危险因素的影响
2. The effect of testosterone on cardiometabolic risk factors in atorvastatin-treated men with late-onset hypogonadism [J] . Krysiak Robert, Gilowski Wojciech, Okopien Boguslaw Pharmacological reports: PR . 2016,第1期

机译：睾丸激素对阿托伐他汀治疗的男性迟发性腺功能减退症患者心脏代谢危险因素的影响
3. Re: The Effect of Testosterone on Cardiometabolic Risk Factors in Atorvastatin-Treated Men with Late-Onset Hypogonadism Editorial Comment [J] . Seftel Allen D. The Journal of Urology . 2016,第6期

机译：回复：睾丸激素对阿托伐他汀治疗的迟发性性腺功能减退症男子的心脏代谢危险因素的影响编辑评论
4. Combine biological experiments, statistical analysis, and semantic search to discover association among high-sensitive C-reactive protein, body fat mass distribution, and other cardiometabolic risk factors in young healthy women [C] . Bin Wu, Jingshan Huang, Mohan Vamsi Kasukurthi, IEEE International Conference on Bioinformatics and Biomedicine . 2017

机译：结合生物学实验，统计分析和语义搜索，发现年轻健康女性的高敏C反应蛋白，体脂质量分布和其他心脏代谢危险因素之间的关联
5. The Long-Term Effects of Testosterone Replacement Therapy in Aging Males with Late-Onset Hypogonadism [D] . ?Clausen, Jonathan 2020

机译：睾酮替代疗法在衰老男性中的长期效应患有晚期失败的性腺
6. Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia [O] . Shoba Sujana Kumar, Karen A Lahey, Andrew Day, 2009

机译：依泽替米贝联合非诺贝特联合阿托伐他汀单药治疗血脂异常的疗效比较
7. Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia [O] . Lahey Karen A, Kumar Shoba, Day Andrew, 2009

机译：依泽替米贝联合非诺贝特联合阿托伐他汀单药治疗血脂异常的疗效比较

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia

摘要

著录项

相似文献

相关主题

期刊订阅